Global Rapid Microbiology Testing Market

Rapid Microbiology Testing Comprehensive Study by Application (Clinical Disease Diagnosis, Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Cosmetics & Personal Care Products Testing, Environmental Testing, Research Applications, Other Applications (chemicals, paints, and biofuels)), End-users (Diagnostic Laboratories & Hospitals, Pharmaceutical & Biotechnology Companies, Food & Beverage Companies, Contract Research Organizations, Other End Users), Product (Instruments (Automated ID/AST Systems, Mass Spectrometers, PCR Systems, Cytometers, Active Air Samplers, Bioluminescence- and Fluorescence-based Detection Systems), Reagents & Kits (Sterility Testing Reagents & Kits, Other Reagents & Kits), Consumables), Method (Growth-based, Viability-based, Cellular Component-based, Nucleic Acid-based, Other Rapid Microbiology Testing Methods) Players and Region - Global Market Outlook to 2026

Rapid Microbiology Testing Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Rapid Microbiology Testing Market?

Microorganisms can harmful to humans as they can spoil food, introduce toxins, cause disease and lead to a host of other problems. Thus it is important to identify these contaminants and treat them before they do irreversible damage. Microbiology testing is an examination of the microscopic organisms in the given sample. Rapid microbiology testing helps to expose microbial contamination in a matter of hours as opposed to the days required for traditional methods. It detects the presence of a single organism within hours.

The market study is being classified, by Application (Clinical Disease Diagnosis, Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Cosmetics & Personal Care Products Testing, Environmental Testing, Research Applications and Other Applications (chemicals, paints, and biofuels)) and major geographies with country level break-up.

Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), bioMérieux (France), BD (United States), Danaher (United States), Thermo Fisher (United States), Bio-Rad (United States), Accelerate (United States) and Alifax (Italy) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Creative Diagnostics (United States), Merck Group(Germany), Synbiosis (United Kingdom), Bioanalyse (Turkey) and Zhuhai DL Biotech (China).

The major players are investing in the rapid microbiology testing market. They are focusing on research and development activities. It helps to gain competitive advantage in the market. They are also focusing on acquisitions and partnerships in the new markets.

Segment Analysis
Analyst at AMA have segmented the market study of Global Rapid Microbiology Testing market by Type, Application and Region.

On the basis of geography, the market of Rapid Microbiology Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increased Acceptance of Rapid Microbiology Testing
  • Increased Incidences of Infectious Diseases
  • Rise in the Food Safety Concerns

Market Trend
  • Increased Research and Development Investments

Restraints
  • Unfavorable Reimbursement Policies

Opportunities
  • Increasing Opportunities from Developing Regions
  • Growth in the Healthcare Industry Worldwide
  • Rise in the Number of Diagnostic Laboratories in Developing Regions

Challenges
  • High Cost of Rapid Microbiology Testing Instruments


Market Leaders and some development strategies
Recently, Bruker has announced the closing of its acquisition of MERLIN Diagnostika GmbH, located near Bonn, Germany. MERLIN has in-depth expertise in products, services and consulting in the fields of antibiotic resistance testing (ART) and antibiotic susceptibility testing (AST).



Key Target Audience
Rapid Microbiology Testing Providers, Emerging Companies, Research Professionals and End-users

Report Objectives / Segmentation Covered

By Application
  • Clinical Disease Diagnosis
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Cosmetics & Personal Care Products Testing
  • Environmental Testing
  • Research Applications
  • Other Applications (chemicals, paints, and biofuels)
By End-users
  • Diagnostic Laboratories & Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Food & Beverage Companies
  • Contract Research Organizations
  • Other End Users

By Product
  • Instruments (Automated ID/AST Systems, Mass Spectrometers, PCR Systems, Cytometers, Active Air Samplers, Bioluminescence- and Fluorescence-based Detection Systems)
  • Reagents & Kits (Sterility Testing Reagents & Kits, Other Reagents & Kits)
  • Consumables

By Method
  • Growth-based
  • Viability-based
  • Cellular Component-based
  • Nucleic Acid-based
  • Other Rapid Microbiology Testing Methods

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Acceptance of Rapid Microbiology Testing
      • 3.2.2. Increased Incidences of Infectious Diseases
      • 3.2.3. Rise in the Food Safety Concerns
    • 3.3. Market Challenges
      • 3.3.1. High Cost of Rapid Microbiology Testing Instruments
    • 3.4. Market Trends
      • 3.4.1. Increased Research and Development Investments
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Rapid Microbiology Testing, by Application, End-users, Product, Method and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Rapid Microbiology Testing (Value)
      • 5.2.1. Global Rapid Microbiology Testing by: Application (Value)
        • 5.2.1.1. Clinical Disease Diagnosis
        • 5.2.1.2. Food & Beverage Testing
        • 5.2.1.3. Pharmaceutical & Biological Drug Testing
        • 5.2.1.4. Cosmetics & Personal Care Products Testing
        • 5.2.1.5. Environmental Testing
        • 5.2.1.6. Research Applications
        • 5.2.1.7. Other Applications (chemicals, paints, and biofuels)
      • 5.2.2. Global Rapid Microbiology Testing by: End-users (Value)
        • 5.2.2.1. Diagnostic Laboratories & Hospitals
        • 5.2.2.2. Pharmaceutical & Biotechnology Companies
        • 5.2.2.3. Food & Beverage Companies
        • 5.2.2.4. Contract Research Organizations
        • 5.2.2.5. Other End Users
      • 5.2.3. Global Rapid Microbiology Testing by: Product (Value)
        • 5.2.3.1. Instruments (Automated ID/AST Systems, Mass Spectrometers, PCR Systems, Cytometers, Active Air Samplers, Bioluminescence- and Fluorescence-based Detection Systems)
        • 5.2.3.2. Reagents & Kits (Sterility Testing Reagents & Kits, Other Reagents & Kits)
        • 5.2.3.3. Consumables
      • 5.2.4. Global Rapid Microbiology Testing by: Method (Value)
        • 5.2.4.1. Growth-based
        • 5.2.4.2. Viability-based
        • 5.2.4.3. Cellular Component-based
        • 5.2.4.4. Nucleic Acid-based
        • 5.2.4.5. Other Rapid Microbiology Testing Methods
      • 5.2.5. Global Rapid Microbiology Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Rapid Microbiology Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Hi-Media (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. MERLIN (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Liofilchem (Italy)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. BioMérieux (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. BD (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Accelerate (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Alifax (Italy)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Rapid Microbiology Testing Sale, by Application, End-users, Product, Method and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Rapid Microbiology Testing (Value)
      • 7.2.1. Global Rapid Microbiology Testing by: Application (Value)
        • 7.2.1.1. Clinical Disease Diagnosis
        • 7.2.1.2. Food & Beverage Testing
        • 7.2.1.3. Pharmaceutical & Biological Drug Testing
        • 7.2.1.4. Cosmetics & Personal Care Products Testing
        • 7.2.1.5. Environmental Testing
        • 7.2.1.6. Research Applications
        • 7.2.1.7. Other Applications (chemicals, paints, and biofuels)
      • 7.2.2. Global Rapid Microbiology Testing by: End-users (Value)
        • 7.2.2.1. Diagnostic Laboratories & Hospitals
        • 7.2.2.2. Pharmaceutical & Biotechnology Companies
        • 7.2.2.3. Food & Beverage Companies
        • 7.2.2.4. Contract Research Organizations
        • 7.2.2.5. Other End Users
      • 7.2.3. Global Rapid Microbiology Testing by: Product (Value)
        • 7.2.3.1. Instruments (Automated ID/AST Systems, Mass Spectrometers, PCR Systems, Cytometers, Active Air Samplers, Bioluminescence- and Fluorescence-based Detection Systems)
        • 7.2.3.2. Reagents & Kits (Sterility Testing Reagents & Kits, Other Reagents & Kits)
        • 7.2.3.3. Consumables
      • 7.2.4. Global Rapid Microbiology Testing by: Method (Value)
        • 7.2.4.1. Growth-based
        • 7.2.4.2. Viability-based
        • 7.2.4.3. Cellular Component-based
        • 7.2.4.4. Nucleic Acid-based
        • 7.2.4.5. Other Rapid Microbiology Testing Methods
      • 7.2.5. Global Rapid Microbiology Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Rapid Microbiology Testing: by Application(USD Million)
  • Table 2. Rapid Microbiology Testing Clinical Disease Diagnosis , by Region USD Million (2015-2020)
  • Table 3. Rapid Microbiology Testing Food & Beverage Testing , by Region USD Million (2015-2020)
  • Table 4. Rapid Microbiology Testing Pharmaceutical & Biological Drug Testing , by Region USD Million (2015-2020)
  • Table 5. Rapid Microbiology Testing Cosmetics & Personal Care Products Testing , by Region USD Million (2015-2020)
  • Table 6. Rapid Microbiology Testing Environmental Testing , by Region USD Million (2015-2020)
  • Table 7. Rapid Microbiology Testing Research Applications , by Region USD Million (2015-2020)
  • Table 8. Rapid Microbiology Testing Other Applications (chemicals, paints, and biofuels) , by Region USD Million (2015-2020)
  • Table 9. Rapid Microbiology Testing: by End-users(USD Million)
  • Table 10. Rapid Microbiology Testing Diagnostic Laboratories & Hospitals , by Region USD Million (2015-2020)
  • Table 11. Rapid Microbiology Testing Pharmaceutical & Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 12. Rapid Microbiology Testing Food & Beverage Companies , by Region USD Million (2015-2020)
  • Table 13. Rapid Microbiology Testing Contract Research Organizations , by Region USD Million (2015-2020)
  • Table 14. Rapid Microbiology Testing Other End Users , by Region USD Million (2015-2020)
  • Table 15. Rapid Microbiology Testing: by Product(USD Million)
  • Table 16. Rapid Microbiology Testing Instruments (Automated ID/AST Systems, Mass Spectrometers, PCR Systems, Cytometers, Active Air Samplers, Bioluminescence- and Fluorescence-based Detection Systems) , by Region USD Million (2015-2020)
  • Table 17. Rapid Microbiology Testing Reagents & Kits (Sterility Testing Reagents & Kits, Other Reagents & Kits) , by Region USD Million (2015-2020)
  • Table 18. Rapid Microbiology Testing Consumables , by Region USD Million (2015-2020)
  • Table 19. Rapid Microbiology Testing: by Method(USD Million)
  • Table 20. Rapid Microbiology Testing Growth-based , by Region USD Million (2015-2020)
  • Table 21. Rapid Microbiology Testing Viability-based , by Region USD Million (2015-2020)
  • Table 22. Rapid Microbiology Testing Cellular Component-based , by Region USD Million (2015-2020)
  • Table 23. Rapid Microbiology Testing Nucleic Acid-based , by Region USD Million (2015-2020)
  • Table 24. Rapid Microbiology Testing Other Rapid Microbiology Testing Methods , by Region USD Million (2015-2020)
  • Table 25. South America Rapid Microbiology Testing, by Country USD Million (2015-2020)
  • Table 26. South America Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 27. South America Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 28. South America Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 29. South America Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 30. Brazil Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 31. Brazil Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 32. Brazil Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 33. Brazil Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 34. Argentina Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 35. Argentina Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 36. Argentina Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 37. Argentina Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 38. Rest of South America Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 39. Rest of South America Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 40. Rest of South America Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 41. Rest of South America Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 42. Asia Pacific Rapid Microbiology Testing, by Country USD Million (2015-2020)
  • Table 43. Asia Pacific Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 44. Asia Pacific Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 45. Asia Pacific Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 46. Asia Pacific Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 47. China Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 48. China Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 49. China Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 50. China Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 51. Japan Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 52. Japan Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 53. Japan Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 54. Japan Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 55. India Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 56. India Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 57. India Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 58. India Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 59. South Korea Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 60. South Korea Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 61. South Korea Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 62. South Korea Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 63. Taiwan Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 64. Taiwan Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 65. Taiwan Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 66. Taiwan Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 67. Australia Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 68. Australia Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 69. Australia Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 70. Australia Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 71. Rest of Asia-Pacific Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 72. Rest of Asia-Pacific Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 73. Rest of Asia-Pacific Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 74. Rest of Asia-Pacific Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 75. Europe Rapid Microbiology Testing, by Country USD Million (2015-2020)
  • Table 76. Europe Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 77. Europe Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 78. Europe Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 79. Europe Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 80. Germany Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 81. Germany Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 82. Germany Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 83. Germany Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 84. France Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 85. France Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 86. France Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 87. France Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 88. Italy Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 89. Italy Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 90. Italy Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 91. Italy Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 92. United Kingdom Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 93. United Kingdom Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 94. United Kingdom Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 95. United Kingdom Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 96. Netherlands Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 97. Netherlands Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 98. Netherlands Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 99. Netherlands Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 100. Rest of Europe Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 101. Rest of Europe Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 102. Rest of Europe Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 103. Rest of Europe Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 104. MEA Rapid Microbiology Testing, by Country USD Million (2015-2020)
  • Table 105. MEA Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 106. MEA Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 107. MEA Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 108. MEA Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 109. Middle East Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 110. Middle East Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 111. Middle East Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 112. Middle East Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 113. Africa Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 114. Africa Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 115. Africa Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 116. Africa Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 117. North America Rapid Microbiology Testing, by Country USD Million (2015-2020)
  • Table 118. North America Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 119. North America Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 120. North America Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 121. North America Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 122. United States Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 123. United States Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 124. United States Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 125. United States Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 126. Canada Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 127. Canada Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 128. Canada Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 129. Canada Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 130. Mexico Rapid Microbiology Testing, by Application USD Million (2015-2020)
  • Table 131. Mexico Rapid Microbiology Testing, by End-users USD Million (2015-2020)
  • Table 132. Mexico Rapid Microbiology Testing, by Product USD Million (2015-2020)
  • Table 133. Mexico Rapid Microbiology Testing, by Method USD Million (2015-2020)
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Rapid Microbiology Testing: by Application(USD Million)
  • Table 145. Rapid Microbiology Testing Clinical Disease Diagnosis , by Region USD Million (2021-2026)
  • Table 146. Rapid Microbiology Testing Food & Beverage Testing , by Region USD Million (2021-2026)
  • Table 147. Rapid Microbiology Testing Pharmaceutical & Biological Drug Testing , by Region USD Million (2021-2026)
  • Table 148. Rapid Microbiology Testing Cosmetics & Personal Care Products Testing , by Region USD Million (2021-2026)
  • Table 149. Rapid Microbiology Testing Environmental Testing , by Region USD Million (2021-2026)
  • Table 150. Rapid Microbiology Testing Research Applications , by Region USD Million (2021-2026)
  • Table 151. Rapid Microbiology Testing Other Applications (chemicals, paints, and biofuels) , by Region USD Million (2021-2026)
  • Table 152. Rapid Microbiology Testing: by End-users(USD Million)
  • Table 153. Rapid Microbiology Testing Diagnostic Laboratories & Hospitals , by Region USD Million (2021-2026)
  • Table 154. Rapid Microbiology Testing Pharmaceutical & Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 155. Rapid Microbiology Testing Food & Beverage Companies , by Region USD Million (2021-2026)
  • Table 156. Rapid Microbiology Testing Contract Research Organizations , by Region USD Million (2021-2026)
  • Table 157. Rapid Microbiology Testing Other End Users , by Region USD Million (2021-2026)
  • Table 158. Rapid Microbiology Testing: by Product(USD Million)
  • Table 159. Rapid Microbiology Testing Instruments (Automated ID/AST Systems, Mass Spectrometers, PCR Systems, Cytometers, Active Air Samplers, Bioluminescence- and Fluorescence-based Detection Systems) , by Region USD Million (2021-2026)
  • Table 160. Rapid Microbiology Testing Reagents & Kits (Sterility Testing Reagents & Kits, Other Reagents & Kits) , by Region USD Million (2021-2026)
  • Table 161. Rapid Microbiology Testing Consumables , by Region USD Million (2021-2026)
  • Table 162. Rapid Microbiology Testing: by Method(USD Million)
  • Table 163. Rapid Microbiology Testing Growth-based , by Region USD Million (2021-2026)
  • Table 164. Rapid Microbiology Testing Viability-based , by Region USD Million (2021-2026)
  • Table 165. Rapid Microbiology Testing Cellular Component-based , by Region USD Million (2021-2026)
  • Table 166. Rapid Microbiology Testing Nucleic Acid-based , by Region USD Million (2021-2026)
  • Table 167. Rapid Microbiology Testing Other Rapid Microbiology Testing Methods , by Region USD Million (2021-2026)
  • Table 168. South America Rapid Microbiology Testing, by Country USD Million (2021-2026)
  • Table 169. South America Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 170. South America Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 171. South America Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 172. South America Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 173. Brazil Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 174. Brazil Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 175. Brazil Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 176. Brazil Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 177. Argentina Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 178. Argentina Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 179. Argentina Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 180. Argentina Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 181. Rest of South America Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 182. Rest of South America Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 183. Rest of South America Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 184. Rest of South America Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 185. Asia Pacific Rapid Microbiology Testing, by Country USD Million (2021-2026)
  • Table 186. Asia Pacific Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 187. Asia Pacific Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 188. Asia Pacific Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 189. Asia Pacific Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 190. China Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 191. China Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 192. China Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 193. China Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 194. Japan Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 195. Japan Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 196. Japan Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 197. Japan Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 198. India Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 199. India Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 200. India Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 201. India Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 202. South Korea Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 203. South Korea Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 204. South Korea Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 205. South Korea Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 206. Taiwan Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 207. Taiwan Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 208. Taiwan Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 209. Taiwan Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 210. Australia Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 211. Australia Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 212. Australia Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 213. Australia Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 216. Rest of Asia-Pacific Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 217. Rest of Asia-Pacific Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 218. Europe Rapid Microbiology Testing, by Country USD Million (2021-2026)
  • Table 219. Europe Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 220. Europe Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 221. Europe Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 222. Europe Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 223. Germany Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 224. Germany Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 225. Germany Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 226. Germany Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 227. France Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 228. France Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 229. France Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 230. France Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 231. Italy Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 232. Italy Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 233. Italy Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 234. Italy Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 235. United Kingdom Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 236. United Kingdom Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 237. United Kingdom Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 238. United Kingdom Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 239. Netherlands Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 240. Netherlands Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 241. Netherlands Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 242. Netherlands Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 243. Rest of Europe Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 244. Rest of Europe Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 245. Rest of Europe Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 246. Rest of Europe Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 247. MEA Rapid Microbiology Testing, by Country USD Million (2021-2026)
  • Table 248. MEA Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 249. MEA Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 250. MEA Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 251. MEA Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 252. Middle East Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 253. Middle East Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 254. Middle East Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 255. Middle East Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 256. Africa Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 257. Africa Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 258. Africa Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 259. Africa Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 260. North America Rapid Microbiology Testing, by Country USD Million (2021-2026)
  • Table 261. North America Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 262. North America Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 263. North America Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 264. North America Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 265. United States Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 266. United States Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 267. United States Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 268. United States Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 269. Canada Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 270. Canada Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 271. Canada Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 272. Canada Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 273. Mexico Rapid Microbiology Testing, by Application USD Million (2021-2026)
  • Table 274. Mexico Rapid Microbiology Testing, by End-users USD Million (2021-2026)
  • Table 275. Mexico Rapid Microbiology Testing, by Product USD Million (2021-2026)
  • Table 276. Mexico Rapid Microbiology Testing, by Method USD Million (2021-2026)
  • Table 277. Research Programs/Design for This Report
  • Table 278. Key Data Information from Secondary Sources
  • Table 279. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Rapid Microbiology Testing: by Application USD Million (2015-2020)
  • Figure 5. Global Rapid Microbiology Testing: by End-users USD Million (2015-2020)
  • Figure 6. Global Rapid Microbiology Testing: by Product USD Million (2015-2020)
  • Figure 7. Global Rapid Microbiology Testing: by Method USD Million (2015-2020)
  • Figure 8. South America Rapid Microbiology Testing Share (%), by Country
  • Figure 9. Asia Pacific Rapid Microbiology Testing Share (%), by Country
  • Figure 10. Europe Rapid Microbiology Testing Share (%), by Country
  • Figure 11. MEA Rapid Microbiology Testing Share (%), by Country
  • Figure 12. North America Rapid Microbiology Testing Share (%), by Country
  • Figure 13. Global Rapid Microbiology Testing share by Players 2020 (%)
  • Figure 14. Global Rapid Microbiology Testing share by Players (Top 3) 2020(%)
  • Figure 15. Global Rapid Microbiology Testing share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Hi-Media (India) Revenue, Net Income and Gross profit
  • Figure 18. Hi-Media (India) Revenue: by Geography 2020
  • Figure 19. MERLIN (Germany) Revenue, Net Income and Gross profit
  • Figure 20. MERLIN (Germany) Revenue: by Geography 2020
  • Figure 21. Liofilchem (Italy) Revenue, Net Income and Gross profit
  • Figure 22. Liofilchem (Italy) Revenue: by Geography 2020
  • Figure 23. BioMérieux (France) Revenue, Net Income and Gross profit
  • Figure 24. BioMérieux (France) Revenue: by Geography 2020
  • Figure 25. BD (United States) Revenue, Net Income and Gross profit
  • Figure 26. BD (United States) Revenue: by Geography 2020
  • Figure 27. Danaher (United States) Revenue, Net Income and Gross profit
  • Figure 28. Danaher (United States) Revenue: by Geography 2020
  • Figure 29. Thermo Fisher (United States) Revenue, Net Income and Gross profit
  • Figure 30. Thermo Fisher (United States) Revenue: by Geography 2020
  • Figure 31. Bio-Rad (United States) Revenue, Net Income and Gross profit
  • Figure 32. Bio-Rad (United States) Revenue: by Geography 2020
  • Figure 33. Accelerate (United States) Revenue, Net Income and Gross profit
  • Figure 34. Accelerate (United States) Revenue: by Geography 2020
  • Figure 35. Alifax (Italy) Revenue, Net Income and Gross profit
  • Figure 36. Alifax (Italy) Revenue: by Geography 2020
  • Figure 37. Global Rapid Microbiology Testing: by Application USD Million (2021-2026)
  • Figure 38. Global Rapid Microbiology Testing: by End-users USD Million (2021-2026)
  • Figure 39. Global Rapid Microbiology Testing: by Product USD Million (2021-2026)
  • Figure 40. Global Rapid Microbiology Testing: by Method USD Million (2021-2026)
  • Figure 41. South America Rapid Microbiology Testing Share (%), by Country
  • Figure 42. Asia Pacific Rapid Microbiology Testing Share (%), by Country
  • Figure 43. Europe Rapid Microbiology Testing Share (%), by Country
  • Figure 44. MEA Rapid Microbiology Testing Share (%), by Country
  • Figure 45. North America Rapid Microbiology Testing Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Hi-Media (India)
  • MERLIN (Germany)
  • Liofilchem (Italy)
  • bioMérieux (France)
  • BD (United States)
  • Danaher (United States)
  • Thermo Fisher (United States)
  • Bio-Rad (United States)
  • Accelerate (United States)
  • Alifax (Italy)
Additional players considered in the study are as follows:
Creative Diagnostics (United States) , Merck Group(Germany) , Synbiosis (United Kingdom) , Bioanalyse (Turkey) , Zhuhai DL Biotech (China)
Select User Access Type

Key Highlights of Report


Nov 2021 214 Pages 77 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Rapid Microbiology Testing Market Quantitative research analysis
Global Rapid Microbiology Testing Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increased Acceptance of Rapid Microbiology Testing " is seen as one of major growth factors of Rapid Microbiology Testing Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
will lead Rapid Microbiology Testing Market in coming years.

Know More About Global Rapid Microbiology Testing Market Report?

Have a Query? Click Here

Other Related Reports

Travel Nursing Staffing Comprehensive Study by Type (Temporary, Permanent), Service (Examining Patients, Labor & Delivery, Critical Care / ICU, Operating Room, Emergency Room, Telemetry, Others), End...
$ 3450
Medical Equipment Financing Comprehensive Study by Type (Refurbished Equipment, New Medical Equipment, Rental Equipment), Equipment (Diagnostic, Therapeutic, Patient Monitoring, Laboratory, Medical F...
$ 3650
Water Therapy System Comprehensive Study by Application (Fibromyalgia, Osteoarthritis, Arthritis, Other), Technology (Water softeners, Reverse osmosis systems, Distillation systems, Disinfection meth...
$ 3500
Online Doctor Consultation Comprehensive Study by Type (Video Chat, Audio Chat), Application (Health Education, Medical Information Inquiries, Online Disease Counseling, Teleconsultation, Teletherapy...
$ 3750
Medical Writing Comprehensive Study by Type (Regulatory Medical Writing, Education Medical Writing), Application (Medical or Scientific Journalism, Medical Marketing), End Users (Pharmaceutical and B...
$ 4250
Diagnostic Tests Comprehensive Study by Type (CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte Testing, HbA1c, CMP, Liver Panel, Renal Panel, Lipid Panel), Application (Central Laboratories, Primary Cl...
$ 3650